CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 900 enrolled
Drug / intervention
No Financial Incentive +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04328207
NCT04328207N/ACompleted

Using Telemedicine to Prevent Blindness in an At-risk Rural Alabama Population

University of Alabama at Birmingham·interventional·Posted Mar 31, 2020·Updated Aug 7, 2025

In Brief

A clinical study evaluating No Financial Incentive and Financial Incentive for Glaucoma and 4 related conditions. Completed, enrolled 900 participants across 1 site.

Detailed Summary

Glaucoma is a blinding eye disease increasingly common in older adults, particularly in African Americans, and often diagnosed late in the disease course. It is essential to develop novel health care models, utilizing telemedicine, to improve the ability to detect glaucoma at an earlier stage, and to provide a platform to manage this disease in community-based clinics so that further vision loss is prevented. Our goal is to improve the quality and accessibility of glaucoma detection and management among a vulnerable and at-risk segment of our population.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedMar 31, 2020
Enrollment StartNov 18, 2020
Primary CompletionJul 1, 2024
TodayJul 2, 2026
Enrollment to primary: 3.6 yearsPosted 6.3 years ago

Interventions

No Financial Incentiveother

Standard of care eye health education

Financial Incentivebehavioral

Patients who are referred for an in-person follow-up exam will receive a financial incentive once the referral visit is completed.